These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 19660875)

  • 1. ECT for Parkinson's disease.
    Popeo D; Kellner CH
    Med Hypotheses; 2009 Oct; 73(4):468-9. PubMed ID: 19660875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement.
    Cumper SK; Ahle GM; Liebman LS; Kellner CH
    J ECT; 2014 Jun; 30(2):122-4. PubMed ID: 24810775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electric stimulation (ECT) in Parkinson disease].
    Dam H; Pakkenberg H; Bolwig TG
    Ugeskr Laeger; 1992 Jan; 154(4):183-7. PubMed ID: 1736441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electroconvulsive therapy in the treatment of Parkinson disease].
    Jeanneau A
    Encephale; 1993; 19(5):573-8. PubMed ID: 8306926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.
    Borisovskaya A; Bryson WC; Buchholz J; Samii A; Borson S
    Neurodegener Dis Manag; 2016 Apr; 6(2):161-76. PubMed ID: 27033556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroconvulsive therapy in Parkinson's disease and other movement disorders.
    Faber R; Trimble MR
    Mov Disord; 1991; 6(4):293-303. PubMed ID: 1758447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease.
    Ueda S; Koyama K; Okubo Y
    J ECT; 2010 Jun; 26(2):111-5. PubMed ID: 20386461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature.
    Wilkins KM; Ostroff R; Tampi RR
    J Geriatr Psychiatry Neurol; 2008 Mar; 21(1):3-11. PubMed ID: 18287164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electroconvulsive therapy in Parkinson disease. Description of three cases].
    Avila A; Sastre F; Cardona X; Maho P; Bello J; Sancho I
    Neurologia; 1997; 12(7):313-6. PubMed ID: 9432202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.
    Raskin S; Durst R
    Med Hypotheses; 2010 Dec; 75(6):544-6. PubMed ID: 20708340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deep brain stimulation for Parkinson's disease and dystonia].
    Yokochi F
    Brain Nerve; 2009 Apr; 61(4):473-83. PubMed ID: 19378817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bitemporal electroconvulsive therapy for depression in a Parkinson disease patient with a deep-brain stimulator.
    Bailine S; Kremen N; Kohen I; Linder H; Schwartz GJ; Mogilner AY; Pourfar M
    J ECT; 2008 Jun; 24(2):171-2. PubMed ID: 18580566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Parkinson's disease with electroconvulsive therapy.
    Rasmussen K; Abrams R
    Psychiatr Clin North Am; 1991 Dec; 14(4):925-33. PubMed ID: 1771154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of depression in Parkinson's disease.
    Sawabini KA; Watts RL
    Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S37-41. PubMed ID: 15109585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electroconvulsive therapy for neurological disorders].
    Doi N; Sameshima T; Suwa H; Mera H; Nagao T; Yokochi M; Nakamura M; Isse K
    Brain Nerve; 2007 Apr; 59(4):313-20. PubMed ID: 17447517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter to the editor: successful use of electroconvulsive therapy for refractory anxiety in Parkinson's disease.
    Marino L; Friedman JH
    Int J Neurosci; 2013 Jan; 123(1):70-1. PubMed ID: 23038993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECT for Parkinson's?
    Martin BA
    CMAJ; 2003 May; 168(11):1391-2; author reply 1392. PubMed ID: 12771059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electroconvulsive therapy in neurologic diseases].
    Folkerts H
    Nervenarzt; 1995 Apr; 66(4):241-51. PubMed ID: 7783810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.